Edward Overton, DO
Pain Medicine · Charlotte, NCNPI 1093753329
Payments from drug & device makers
Across 247 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$688
- Abbott$563
- Pfizer$311
- AbbVie$282
- Indivior Inc.$226
- Arbor Pharmaceuticals, Inc.$184
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,84999%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 51 | $688 |
| Abbott | 34 | $563 |
| Pfizer | 33 | $311 |
| AbbVie | 13 | $282 |
| Indivior Inc. | 13 | $226 |
| Arbor Pharmaceuticals, Inc. | 12 | $184 |
| Orexo US, Inc. | 8 | $153 |
| Braeburn Inc. | 3 | $136 |
| Assertio Therapeutics, Inc. | 11 | $112 |
| Boston Scientific | 7 | $111 |
| Almatica Pharma LLC | 6 | $110 |
| Forte Bio-pharma LLC | 5 | $103 |
| Collegium Pharmaceutical, Inc. | 5 | $100 |
| Upsher-smith Laboratories LLC | 4 | $73 |
| IBSA Pharma Inc. | 4 | $63 |
| Vertex | 3 | $62 |
| Kowa Pharmaceuticals America, Inc. | 4 | $60 |
| Hikma Pharmaceuticals USA | 3 | $52 |
| Virtus Pharmaceuticals LLC | 3 | $49 |
| Biodelivery Sciences International, Inc. | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 2 | $44 |
| Tonix Medicines, Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Medline Industries LP | 2 | $33 |
| Nevro Corp. | 1 | $29 |
| Lilly USA, LLC | 2 | $26 |
| Fidia Pharma USA Inc. | 1 | $24 |
| GRT US Holding, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Zimmer Biomet | 1 | $16 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Pear Therapeutics (US), Inc. | 1 | $15 |
| Nalu Medical, Inc. | 1 | $13 |
| Saluda Medical Americas, Inc. | 1 | $10 |
How this compares
$3,870 in reported general payments places this provider in the 45th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 15 | $13,685 |
| BelbucaBuprenorphine Hcl | 19 | $8,523 |
| Buprenorphine | 35 | $6,987 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 116 | $6,073 |
| ZtlidoLidocaine | 14 | $5,886 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 241 | $5,313 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $3,111 |
| Tramadol Hcl | 237 | $2,882 |
| Gabapentin | 207 | $2,070 |
| Morphine Sulfate ErMorphine Sulfate | 64 | $1,877 |
| Diclofenac Sodium | 20 | $1,438 |
| Oxycodone Hcl | 87 | $1,240 |
| Cyclobenzaprine Hcl | 122 | $1,003 |
| Pregabalin | 60 | $998 |
| Morphine Sulfate | 30 | $605 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate | $52 | $13,665181 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $100 | $8,52319 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $688 | $5,88614 claims |
| Upsher-smith Laboratories LLCTopiramate | $73 | $31360 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 182 pain medicine providers in North Carolina.
Other pain medicine in Charlotte
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- James DeeringCharlotte$93K
- Ankur ManvarCharlotte$33K
- Russell DavenportCharlotte$26K
- Gerald AronoffCharlotte$17K
- Raza KhanCharlotte$12K
- Adewunmi AkandeCharlotte$12K
- Alexander RothkrugCharlotte$10K
- Cameron CunninghamCharlotte$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.